Table 3. Summary of pancreatic juice proteomic biomarkers proposed for the management of pancreatic cancer.

Single biomarker or panel	Utility	Expression patterna	Impact in prognosis	Year	Ref.
AMYP, PRSS1, GP2-1, CCDC132, REG-1-Alpha, REG-1-Beta, REG-3-Alpha, and LIPRP2	Diagnostic	↑, ↑, ↑, ↑, ↑, ↑, ↑, and ↓	-	2014	[105]
Mucins and S100A8 or S100A9	Prognostic	All ↑	Negative	2014	[106]
MUC-1	Diagnostic	↑	-	2015	[107]
CPA5, LIPRP1, KLK1, HBD, and TTR	Diagnostic	↓, ↓, ↓, ↑, and ↑	-	2015	[108]

^a Expression pattern observed in pancreatic cancer patients. ↑: upregulated. ↓ downregulated.